CStone Pharmaceuticals
HKEX:2616

Watchlist Manager
CStone Pharmaceuticals Logo
CStone Pharmaceuticals
HKEX:2616
Watchlist
Price: 2.36 HKD 2.61%
Market Cap: 3B HKD
Have any thoughts about
CStone Pharmaceuticals?
Write Note

CStone Pharmaceuticals
Common Shares Outstanding

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CStone Pharmaceuticals
Common Shares Outstanding Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Shares Outstanding CAGR 3Y CAGR 5Y CAGR 10Y
CStone Pharmaceuticals
HKEX:2616
Common Shares Outstanding
ÂĄ1.3B
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Common Shares Outstanding
ÂĄ1.4B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Common Shares Outstanding
ÂĄ1.6B
CAGR 3-Years
4%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Common Shares Outstanding
ÂĄ1.3B
CAGR 3-Years
28%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Common Shares Outstanding
ÂĄ2.4B
CAGR 3-Years
14%
CAGR 5-Years
8%
CAGR 10-Years
4%
Imeik Technology Development Co Ltd
SZSE:300896
Common Shares Outstanding
ÂĄ301.3m
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
N/A
No Stocks Found

CStone Pharmaceuticals
Glance View

Market Cap
3B HKD
Industry
Biotechnology

Cstone Pharmaceuticals Co. Ltd. engages in the research and development of highly complex biopharmaceutical products. The company is headquartered in Shanghai, Shanghai and currently employs 264 full-time employees. The company went IPO on 2019-02-26. Through its subsidiaries, the Company is primarily engaged in development, manufacturing and sales of biopharmaceutical products. Its main products include immuno-oncology drugs and molecularly targeted drugs. The firm conducts its businesses mainly in domestic market.

Intrinsic Value
2.93 HKD
Undervaluation 19%
Intrinsic Value
Price

See Also

What is CStone Pharmaceuticals's Common Shares Outstanding?
Common Shares Outstanding
1.3B CNY

Based on the financial report for Jun 30, 2024, CStone Pharmaceuticals's Common Shares Outstanding amounts to 1.3B CNY.

What is CStone Pharmaceuticals's Common Shares Outstanding growth rate?
Common Shares Outstanding CAGR 5Y
5%

Over the last year, the Common Shares Outstanding growth was 0%. The average annual Common Shares Outstanding growth rates for CStone Pharmaceuticals have been 3% over the past three years , 5% over the past five years .

Back to Top